Term	Overlap	P.value	Adjusted.P.value	Old.P.value	Old.Adjusted.P.value	Odds.Ratio	Combined.Score	Genes
Ribosome	79/158	5.23330624743606e-123	6.54163280929508e-121	0	0	181.036697247706	50973.2216817714	RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP1;RPLP0;RPL10A;RPL8;RPL9;RPL6;RPL7;RPS15;RPS4X;RPS14;RPL7A;RPS17;RPS16;RPL18A;RPS19;RPL36AL;RPS18;RPL36;RPL35;RPLP2;RPL38;RPL37;RPS11;RPL39;RPS13;RPS12;RPS9;RPL21;RPS7;RPS8;RPL23;RPS5;RPL22;RPS6;RPL13A;RPSA;RPS3A;RPL37A;RPL24;RPL27;RPL26;RPL29;RPL28;UBA52;RPL10;RPL12;RPL11;RPL36A;RPS4Y1;RPS15A;RPL14;RPS3;RPL13;RPL15;RPS2;RPL18;RPS27A;RPL17;RPL19;RPL41;RPL35A;RPL23A;RPS26;RPS25;RPS27;RPS29;RPL27A;RPS20;FAU;RPS21;RPS24;RPS23
Coronavirus disease	79/232	3.532246859838e-106	2.20765428739875e-104	0	0	93.1259219284044	22612.0993347467	RPL4;RPL5;RPL30;RPL3;RPL32;RPL31;RPL34;RPLP1;RPLP0;RPL10A;RPL8;RPL9;RPL6;RPL7;RPS15;RPS4X;RPS14;RPL7A;RPS17;RPS16;RPL18A;RPS19;RPS18;RPL36AL;RPL36;RPL35;RPLP2;RPL38;RPL37;RPS11;RPL39;RPS13;RPS12;RPS9;RPS7;RPL21;RPS8;RPS5;RPL23;RPL22;RPS6;RPL13A;RPSA;RPS3A;RPL37A;RPL24;RPL27;RPL26;RPL29;UBA52;RPL28;RPL10;RPL12;RPL11;RPL36A;RPS4Y1;RPS15A;RPL14;RPS3;RPL13;RPL15;RPS2;RPL18;RPS27A;RPL17;RPL19;RPL41;RPL35A;RPL23A;RPS26;RPS25;RPS27;RPS29;RPL27A;RPS20;FAU;RPS21;RPS24;RPS23
RNA transport	7/186	0.00192661205239579	0.0762186416271461	0	0	4.24182845149542	26.5198785276961	EEF1A1;EIF2S3;EIF3H;EIF3E;PABPC1;EIF3F;EIF4B
Hematopoietic cell lineage	5/99	0.00243899653206868	0.0762186416271461	0	0	5.73131031275433	34.4805290350811	FLT3LG;CD37;IL7R;MS4A1;CD55
Acute myeloid leukemia	4/67	0.00365411783605119	0.0913529459012797	0	0	6.81469979296066	38.2434176731944	MYC;LEF1;TCF7;PIM1
Thyroid cancer	3/37	0.0050214604824217	0.104613760050452	0	0	9.43306836248013	49.9389889258111	MYC;LEF1;TCF7
Endometrial cancer	3/58	0.0172780087209216	0.290917795680191	0	0	5.82515970515971	23.6403665518867	MYC;LEF1;TCF7
JAK-STAT signaling pathway	5/162	0.0186187389235322	0.290917795680191	0	0	3.42052138804775	13.6259436330412	SOCS3;MYC;PIM1;OSM;IL7R
Mitophagy	3/68	0.0262243293233242	0.36422679615728	0	0	4.92648648648649	17.937670815361	TOMM7;RPS27A;UBA52
Parkinson disease	6/249	0.0305805278072473	0.370275370383794	0	0	2.65486365486366	9.25854978985854	UQCRB;COX4I1;RPS27A;UBA52;COX7C;SLC25A6
Kaposi sarcoma-associated herpesvirus infection	5/193	0.0359125948828432	0.370275370383794	0	0	2.85199395419137	9.48763477801038	MYC;TCF7;LEF1;RPS27A;UBA52
Oxidative phosphorylation	4/133	0.0369767839951712	0.370275370383794	0	0	3.3169868554095	10.9376481370093	UQCRB;PPA1;COX4I1;COX7C
Ubiquitin mediated proteolysis	4/140	0.0432990122081399	0.370275370383794	0	0	3.14514066496164	9.87456369749324	SOCS3;RPS27A;UBA52;BIRC3
Colorectal cancer	3/86	0.0474431311504125	0.370275370383794	0	0	3.8545750569847	11.7496063642768	MYC;LEF1;TCF7
Cardiac muscle contraction	3/87	0.0488095885412964	0.370275370383794	0	0	3.80849420849421	11.5009993487902	UQCRB;COX4I1;COX7C
Primary immunodeficiency	2/38	0.049540053274249	0.370275370383794	0	0	5.90681003584229	17.7498092784478	CD79A;IL7R
PI3K-Akt signaling pathway	7/354	0.050357450372196	0.370275370383794	0	0	2.16942379034184	6.48355881189756	LPAR6;MYC;RPS6;OSM;FLT3LG;IL7R;EIF4B
Non-alcoholic fatty liver disease	4/155	0.0587654796486352	0.408093608671078	0	0	2.83054995680967	8.02234660467191	SOCS3;UQCRB;COX4I1;COX7C
Pathways in cancer	9/531	0.0639975972055052	0.421036823720429	0	0	1.85802350221537	5.10753890237245	LPAR6;MYC;TCF7;LEF1;PIM1;FLT3LG;RASGRP2;IL7R;BIRC3
Hippo signaling pathway	4/163	0.0680698475318147	0.425436547073842	0	0	2.6870385561936	7.22066625167752	MYC;TCF7;LEF1;BIRC3
Salmonella infection	5/249	0.0863664845307135	0.514086217444723	0	0	2.19116724894742	5.36650951409039	MYC;TCF7;LEF1;RPS3;BIRC3
Legionellosis	2/57	0.100342715654893	0.570129066220985	0	0	3.86256109481916	8.88066062812988	EEF1A1;EEF1G
Basal cell carcinoma	2/63	0.118486731946225	0.643949630142525	0	0	3.48157941124625	7.42604974597782	LEF1;TCF7
Diabetic cardiomyopathy	4/203	0.124846023622909	0.650239706369319	0	0	2.14256062923312	4.45797043463442	UQCRB;COX4I1;COX7C;SLC25A6
Central carbon metabolism in cancer	2/70	0.140577997379823	0.666955404268721	0	0	3.12207463630614	6.12548796607774	LDHB;MYC
Adherens junction	2/71	0.143803223610271	0.666955404268721	0	0	3.07667134174848	5.96661770492495	LEF1;TCF7
Cytokine-cytokine receptor interaction	5/295	0.145826992914866	0.666955404268721	0	0	1.83926889014509	3.54120755460348	OSM;CCR7;CCR6;LTB;IL7R
Breast cancer	3/147	0.160858669759865	0.666955404268721	0	0	2.21486486486487	4.04706559365468	MYC;TCF7;LEF1
Huntington disease	5/306	0.162144383081236	0.666955404268721	0	0	1.77105459034548	3.22202309671426	UQCRB;COX4I1;TAF4B;COX7C;SLC25A6
Arrhythmogenic right ventricular cardiomyopathy	2/77	0.163461270024556	0.666955404268721	0	0	2.82967741935484	5.12505287697454	LEF1;TCF7
Gastric cancer	3/149	0.165404940258643	0.666955404268721	0	0	2.18430211032951	3.93034284900416	MYC;TCF7;LEF1
Thermogenesis	4/232	0.175175528489754	0.684279408163101	0	0	1.86727688787185	3.2527343223097	UQCRB;COX4I1;RPS6;COX7C
Hepatitis C	3/157	0.183955458710338	0.696800979963403	0	0	2.06998946998947	3.50461973145412	SOCS3;MYC;EIF3E
Wnt signaling pathway	3/166	0.205442525293688	0.744119589187966	0	0	1.95480019897198	3.09364522647484	MYC;TCF7;LEF1
Hepatocellular carcinoma	3/168	0.210294789686411	0.744119589187966	0	0	1.93090909090909	3.01076029178251	MYC;TCF7;LEF1
Small cell lung cancer	2/92	0.214306441686134	0.744119589187966	0	0	2.35627240143369	3.62948022972413	MYC;BIRC3
Prostate cancer	2/97	0.231593379686306	0.763473522744579	0	0	2.23169213355971	3.26445703074195	TCF7;LEF1
Viral protein interaction with cytokine and cytokine receptor	2/100	0.242009135316354	0.763473522744579	0	0	2.16304586350669	3.06888578691104	CCR7;CCR6
Melanogenesis	2/101	0.245486114267925	0.763473522744579	0	0	2.14108830237863	3.00719041086067	TCF7;LEF1
Prion disease	4/273	0.255549544460693	0.763473522744579	0	0	1.57935994827865	2.1547823351279	UQCRB;COX4I1;COX7C;SLC25A6
NF-kappa B signaling pathway	2/104	0.255927358860733	0.763473522744579	0	0	2.07779886148008	2.83175234154559	LTB;BIRC3
Drug metabolism	2/108	0.269860708906915	0.763473522744579	0	0	1.99898559545547	2.61836997495004	IMPDH2;NME2
Chemokine signaling pathway	3/192	0.27014566027554	0.763473522744579	0	0	1.68365508365508	2.20355764285117	CCR7;CCR6;RASGRP2
HIF-1 signaling pathway	2/109	0.273344016516564	0.763473522744579	0	0	1.9802029946739	2.56837109280432	LDHB;RPS6
Propanoate metabolism	1/34	0.274850468188048	0.763473522744579	0	0	3.20515313563442	4.13954527936482	LDHB
TNF signaling pathway	2/112	0.283789040331125	0.770043079464798	0	0	1.92590420332356	2.42572282112466	SOCS3;BIRC3
Pathways of neurodegeneration	6/475	0.289536197878764	0.770043079464798	0	0	1.35966166030132	1.68526657376884	UQCRB;COX4I1;RPS27A;UBA52;COX7C;SLC25A6
Proteoglycans in cancer	3/205	0.303359234039341	0.789998005310783	0	0	1.57425742574257	1.87783342564193	MYC;RPS6;EIF4B
Bladder cancer	1/41	0.3213241220283	0.796704087683368	0	0	2.64331550802139	3.00096915248438	MYC
Ferroptosis	1/41	0.3213241220283	0.796704087683368	0	0	2.64331550802139	3.00096915248438	PCBP2
Vasopressin-regulated water reabsorption	1/44	0.340322932665771	0.796704087683368	0	0	2.45852505907225	2.64994658278212	AQP3
Purine metabolism	2/129	0.342519519357754	0.796704087683368	0	0	1.66666666666667	1.78571105346369	IMPDH2;NME2
Basal transcription factors	1/45	0.346537558924458	0.796704087683368	0	0	2.40252795333009	2.54611280466167	TAF4B
FoxO signaling pathway	2/131	0.349344406468217	0.796704087683368	0	0	1.64066016504126	1.72547738239788	IL7R;KLF2
Type II diabetes mellitus	1/46	0.352693947364113	0.796704087683368	0	0	2.34901960784314	2.44804159626133	SOCS3
Pyruvate metabolism	1/47	0.358792640883357	0.796704087683368	0	0	2.29783771215996	2.355308148458	LDHB
Apelin signaling pathway	2/137	0.369670696685083	0.796704087683368	0	0	1.56726403823178	1.55965133307352	RPS6;KLF2
Insulin signaling pathway	2/137	0.369670696685083	0.796704087683368	0	0	1.56726403823178	1.55965133307352	SOCS3;RPS6
Cysteine and methionine metabolism	1/50	0.376747905118404	0.798194714233907	0	0	2.1568263669104	2.1054486101079	LDHB
Signaling pathways regulating pluripotency of stem cells	2/143	0.389744939241058	0.811968623418871	0	0	1.5001143902997	1.41350191935455	MYC;TCF7
Pyrimidine metabolism	1/56	0.411171726565995	0.820195939642337	0	0	1.9209528439475	1.70723593971962	NME2
Spliceosome	2/150	0.412801349573093	0.820195939642337	0	0	1.42865446091253	1.2640574596643	SNRPD2;HNRNPA1
mTOR signaling pathway	2/154	0.425783671603562	0.820195939642337	0	0	1.3907753254103	1.18747717736075	RPS6;EIF4B
Cushing syndrome	2/155	0.429006127481426	0.820195939642337	0	0	1.38161501159604	1.16923878483391	TCF7;LEF1
Cellular senescence	2/156	0.432219109408323	0.820195939642337	0	0	1.37257366289624	1.15134583827013	MYC;SLC25A6
Viral myocarditis	1/60	0.433063456131154	0.820195939642337	0	0	1.79035620411493	1.49829720794947	CD55
Necroptosis	2/159	0.441800154966152	0.82282944858197	0	0	1.34614067529621	1.09965913703582	BIRC3;SLC25A6
Amyotrophic lateral sclerosis	4/364	0.447619220028592	0.82282944858197	0	0	1.17463768115942	0.944188290487299	UQCRB;COX4I1;HNRNPA1;COX7C
Alzheimer disease	4/369	0.457984634151656	0.829306632020915	0	0	1.15824895771292	0.904499365247093	UQCRB;COX4I1;COX7C;SLC25A6
Glycolysis / Gluconeogenesis	1/67	0.469443525801291	0.829306632020915	0	0	1.59990277102577	1.20985811218568	LDHB
Adipocytokine signaling pathway	1/69	0.479404545461336	0.829306632020915	0	0	1.55268952500786	1.14155360392859	SOCS3
Influenza A	2/172	0.48225931049938	0.829306632020915	0	0	1.24237824161923	0.906033306213223	SOCS3;SLC25A6
Prolactin signaling pathway	1/70	0.484315073100214	0.829306632020915	0	0	1.53010927691235	1.10935922597087	SOCS3
p53 signaling pathway	1/73	0.498771923657501	0.84249653156752	0	0	1.46613190730838	1.01985067131189	SESN3
Chronic myeloid leukemia	1/76	0.512825581263391	0.84249653156752	0	0	1.40727272727273	0.939804153837317	MYC
Leishmaniasis	1/77	0.517422477783356	0.84249653156752	0	0	1.38868561778778	0.914998796751556	EEF1A1
MAPK signaling pathway	3/294	0.52404406229338	0.84249653156752	0	0	1.08782390638061	0.702929518628326	MYC;FLT3LG;RASGRP2
RNA degradation	1/79	0.526487232312601	0.84249653156752	0	0	1.35294117647059	0.867949914698542	PABPC1
B cell receptor signaling pathway	1/81	0.53538260228359	0.84249653156752	0	0	1.31898395721925	0.824066412306892	CD79A
Transcriptional misregulation in cancer	2/192	0.540862202738195	0.84249653156752	0	0	1.11046972269383	0.68248440974127	MYC;BIRC3
Complement and coagulation cascades	1/85	0.552677724708293	0.84249653156752	0	0	1.2559205500382	0.744736048630631	CD55
ErbB signaling pathway	1/85	0.552677724708293	0.84249653156752	0	0	1.2559205500382	0.744736048630631	MYC
Rheumatoid arthritis	1/93	0.585370048952612	0.861059767637119	0	0	1.14624505928854	0.613826917518524	LTB
TGF-beta signaling pathway	1/94	0.589285766772147	0.861059767637119	0	0	1.133862342591	0.599636342287352	MYC
mRNA surveillance pathway	1/98	0.604584210398966	0.861059767637119	0	0	1.08688461326424	0.546935893711595	PABPC1
AGE-RAGE signaling pathway in diabetic complications	1/100	0.612019510291886	0.861059767637119	0	0	1.06481931615621	0.522816825885732	PIM1
Human T-cell leukemia virus 1 infection	2/219	0.612459910429643	0.861059767637119	0	0	0.970962786779644	0.476035664532038	MYC;SLC25A6
Longevity regulating pathway	1/102	0.619315727751711	0.861059767637119	0	0	1.04362789220098	0.500043946902583	SESN3
Parathyroid hormone synthesis, secretion and action	1/106	0.633501219561315	0.861059767637119	0	0	1.00366692131398	0.45816727931614	NACA
Glucagon signaling pathway	1/107	0.636964651930545	0.861059767637119	0	0	0.994147916456462	0.448401586129608	LDHB
Insulin resistance	1/108	0.640395527038455	0.861059767637119	0	0	0.984806836923384	0.438898156433407	SOCS3
Ribosome biogenesis in eukaryotes	1/108	0.640395527038455	0.861059767637119	0	0	0.984806836923384	0.438898156433407	FBL
Ras signaling pathway	2/232	0.643787251238598	0.861059767637119	0	0	0.915474520804114	0.403163043624792	FLT3LG;RASGRP2
Toxoplasmosis	1/112	0.653799500326555	0.861059767637119	0	0	0.94912559618442	0.403335239626024	BIRC3
Shigellosis	2/246	0.675265163998996	0.861059767637119	0	0	0.862330336682531	0.33859385983942	RPS27A;UBA52
Growth hormone synthesis, secretion and action	1/119	0.676071444952155	0.861059767637119	0	0	0.89250430526602	0.349376630071242	SOCS3
AMPK signaling pathway	1/120	0.679134586224316	0.861059767637119	0	0	0.884959331326113	0.342422587239993	EEF2
Thyroid hormone signaling pathway	1/121	0.682168914103098	0.861059767637119	0	0	0.877540106951872	0.335639764989865	MYC
Cell cycle	1/124	0.691101701700121	0.861059767637119	0	0	0.856006260597365	0.316267165549663	MYC
Platelet activation	1/124	0.691101701700121	0.861059767637119	0	0	0.856006260597365	0.316267165549663	RASGRP2
Osteoclast differentiation	1/127	0.699784725713897	0.861059767637119	0	0	0.835497835497836	0.29825812772645	SOCS3
Lysosome	1/128	0.702624770391889	0.861059767637119	0	0	0.828877005347594	0.292537455022161	AP3M2
Fluid shear stress and atherosclerosis	1/139	0.732155277839921	0.872838553736148	0	0	0.762380841664729	0.237681878612181	KLF2
Measles	1/139	0.732155277839921	0.872838553736148	0	0	0.762380841664729	0.237681878612181	EIF3H
Apoptosis	1/142	0.739689925578737	0.872838553736148	0	0	0.746046194106269	0.224950981904584	BIRC3
Spinocerebellar ataxia	1/143	0.742154323667133	0.872838553736148	0	0	0.740754688559162	0.220891621480306	SLC25A6
Cell adhesion molecules	1/148	0.754132510428032	0.872838553736148	0	0	0.715377059914875	0.201870237421762	SELL
Phospholipase D signaling pathway	1/148	0.754132510428032	0.872838553736148	0	0	0.715377059914875	0.201870237421762	LPAR6
Oxytocin signaling pathway	1/154	0.767777808299544	0.880479137958193	0	0	0.687113348013002	0.181573068932655	EEF2
Hepatitis B	1/162	0.784806655288939	0.887067870896856	0	0	0.65270535091507	0.158162183772225	MYC
MicroRNAs in cancer	2/310	0.791409692765416	0.887067870896856	0	0	0.6809104873621	0.159291860651768	MYC;PIM1
cGMP-PKG signaling pathway	1/167	0.794812812323583	0.887067870896856	0	0	0.632884479092842	0.145341065121265	SLC25A6
Protein processing in endoplasmic reticulum	1/171	0.802483401838483	0.887702878139914	0	0	0.617867253853413	0.135958048278852	SSR2
NOD-like receptor signaling pathway	1/181	0.820434729261631	0.899599483839507	0	0	0.583244206773619	0.115436230905939	BIRC3
Neutrophil extracellular trap formation	1/189	0.833619560221139	0.903624566688718	0	0	0.55819774718398	0.101579789739362	SLC25A6
Pathogenic Escherichia coli infection	1/197	0.845841036089519	0.903624566688718	0	0	0.535195896540434	0.0896045508852234	RPS3
Focal adhesion	1/201	0.851612605367013	0.903624566688718	0	0	0.524385026737968	0.0842285814630998	BIRC3
Epstein-Barr virus infection	1/202	0.85302159095415	0.903624566688718	0	0	0.52174954106473	0.0829427436903815	MYC
Rap1 signaling pathway	1/210	0.863824728000691	0.907378915967112	0	0	0.501573574188266	0.0734230442079275	RASGRP2
Human cytomegalovirus infection	1/225	0.881996230143021	0.918746073065647	0	0	0.467627960275019	0.058718872591887	MYC
Chemical carcinogenesis	1/239	0.896771954909669	0.919829934939578	0	0	0.439805868871613	0.0479184679499224	MYC
Calcium signaling pathway	1/240	0.897754016501028	0.919829934939578	0	0	0.4379433020831	0.0472362019115236	SLC25A6
Herpes simplex virus 1 infection	2/498	0.950065572151023	0.961161187915712	0	0	0.41874783211932	0.0214500534601986	SOCS3;BIRC3
Human papillomavirus infection	1/331	0.95724532603938	0.961161187915712	0	0	0.315702479338843	0.0137948002058045	TCF7
Neuroactive ligand-receptor interaction	1/341	0.961161187915712	0.961161187915712	0	0	0.306259830135263	0.0121319180344619	LPAR6
